Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells

Endocrinology

Volumn 138, Issue 4, 1997, Pages 1728-1735

  Plymate, Stephen R ^a,b,d   Bae, Victoria L ^c   Maddison, Lisette ^a   Quinn, LeBris S ^a,b   Ware, Joy L ^c  

^a GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; VIRUS T ANTIGEN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CARCINOGENICITY; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; SIMIAN VIRUS 40; TUMOR GROWTH;

EID: 0030960834     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.4.5071     Document Type: Article

References (37)

1. Schillaci R, Ribaudo C, Rondinon C, Rold'an A 1994 Role of insulin-like growth factor-1 on the kinetics of human lymphocyte stimulation in serum-free culture medium. Immunol Cell Biol 72:300-305
2. LeRoith D, Baserga R, Helman L, Roberts C 1995 Insulin-like growth factors and cancer. Ann Intern Med 122:54-59
3. Papa V, Gliozzo B, Clark G, MaGuire WL, Moore D, Fujita-Yamaguchi Y, Vigneri R, Goldfine ID, Pezzino V 1993 Insulin-like growth factor-I receptors are overexprossod and predict a low risk in human breast cancer. Cancer Res 53:3736-3740
4. Pekonon F, Partanen S, Makinen T, Rutaned E-M 1988 Receptors for epidermal growth factor and insulin-like growth factor I and their relationship to steroid receptors in human breast cancer. Cancer Res 48:1343-1347
5. Rauscher FI 1993 The WTI Wilm's tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J 7:896-903
6. Tanaka R, Tshushima T, Murakami H, Shizumi K, Obara T 1994 Insulin-like growth factur-I receptors and insulin-like growth factor binding proteins in human parathyroid tumors. World J Surg 18:635-642
7. Vincent T, Garvin A, Gramling T, Hazen-Martin D, Reg G, Sens D 1994 Expression of insulin-like growth factor binding-protein-2 in Wilm's tumor. Pediatr Pathol 14:723-730
8. Yakovchenko E, Whalin M, Movsesyan V, Guroff G 1996 Insulin-like growth factor I receptor expression and function in nerve growth factor-differentiated PC12 cells. J Neurochem 67:540-548
9. Tennant M, Thrasher J, Twomey P, Drivdahl R, Birnbaum R, Plymate S 1996 Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab 81:3774-3782
10. Tennant M, Twomey P, Thrasher J, Birnbaum R, Plymate S 1996 Comparison of insulin-like growth factor-binding protein-2 and -3 mRNA and protein in normal human prostate epithelium, prostate intraepithelial neoplasia, and malignant tissue. J Clin Endocrinol Metab 81:411-420
11. Tennant M, Thrasher J, Twomey P, Birnbaum R, Plymate S 1996 Insulin-like growth factor-binding proteins (IGFBP)-4, -5, and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization. J Clin Endocrinol Metab 81:3783-3792
12. Plymate S, Ware J, Thrasher J, Chatta K, Birnbaum R 1996 Transformation and immortalization of human prostate epithelial cells alters responsiveness to IGF (IGF)-I and IGF binding protein expression and secretion. J Clin Endocrinol Metab 81:3709-3716
13. Bae V, Jackson-Cook C, Maygarden S, Edelman W, Brothman A, Chen J, Ware JL 1995 A new model for cytogenetic analysis of human prostate cancer progression and metastasis. Cancer Res 36:642 (Abstract)
14. Bae V, Jackson-Cook C, Brothman A, Maygarden S, Ware J 1994 Tumori genicity of SV40 T antigen immortalized human prostate epithelial cells association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 58:721-729
15. Jackson-Cook C, Bae V, Edelman W, Brothman A, Ware J 1996 Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15. Cancer Genet Cvtogenet 87:14-23
16. Scatchard G 1949 The attraction of proteins for small molecules and ions. Ann NY Acacl Sci 51:660-672
17. Baserga R 1995 The insulin-like growth factor receptor: a key to tumor growth? Cancer Res 55:249-252
18. Kaleko M, Rutter W, Miller A 1990 Overexpression of the human insulin-like growth factor I receptor promotes ligand dependent neoplastic transforma-tion. Mol Cell Biol 10:464-473
19. Gibson-D'Ambrosio R, Brady T, D'Ambrosio S 1995 Identification and isolation of human epithelial cell colonies that express specific gene products. BioTechniques 19:784-790
20. Bonnet P, Reiter E, Bruyninx M, Sente B, Dombrowicz D, de Levai J, Closset J, Hennen G 1993 Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5α-reductase and steroid receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab. 77:1203-1208
21. Quinn L, Steinmetz B, Maas A, Ong L, Kaleko M 1994 Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation. J Cell Physiol 159:387-398
22. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger K 1995 Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649
23. Burfeind P, Chemicky C, Rininsland F, Ilan J, Ilan J 1996 Antisense RNA to the type 1 insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci USA 93:7263-7268
24. Connolly JM, Rose DP 1994 Regulation of DU145 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop. Prostate 24:167-175
25. Figueroa J, Lee A, Jackson J, Yee D 1995 Proliferation of cultured human cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an autocrine IGF loop. J Clin Endocrinol Metab 80:3476-3482
26. Pietrzkowski Z, Mulholland G, Gomella L, Jameson B, Wernicke D, Baserga R 1993 Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res 53:1102-1106
27. Sell C, Baserga R, Rubin R 1995 Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent Etoposide-induced apoptosis. Cancer Res 55:303-306
28. Bergmann U, Funatomi H, Yokoyama M, Berger H, Kore M 1995 Insulin-like growth factor-I receptors overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55:2007-2011
29. Daws M, Westley B, May F 1996 Paradoxical effects of overexpression of the type 1 insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol. Endocrinology 137:1177-1186
30. Bondy C, Lee W 1993 Patterns of insulin-like growth factor and IGF receptor gene expression in the brain; functional implications. Ann NY Acad Sci 692:33-43
31. Florini J, Ewton D, Falon S, Van Wyk J 1986 Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am J Physiol 250:C771-C778
32. Lammers R, Gray A, Sclessinger J, Ullrich A 1989 Differential signaling potential of insulin- and insulin- and IGF-I-receptor cytoplasmic domains. EMBO J 8:1369-1375
33. Wu X, Fan Z, Rosen N, Mendelsohn J 1995 Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest 95:1897-1905
34. Ueda K, Ganem D 1996 Apoptosis is induced by N-myc expression in hepatocyte, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor 11. J Virol 70:1375-1383
35. Stewart C, Rotwein P 1996 Insulin-like growth factor-II is an automne survival factor for differentiating myoblasts. J Biol Chem 271:11330-11338
36. Murphy M, Pykett M, Harnish P, Zang K, George D 1993 Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ 4:715-722
37. Blakesley V, Kalebic T, Helman L, Stannard B, Faria N, Roberts CT, LeRoith D 1996 Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor. Endocrinology 137:410-417